LITTLE KNOWN FACTS ABOUT MBL77.

Not all patients with CLL have to have therapy. Even with all modern developments, the iwCLL even now recommends watchful observation for individuals with asymptomatic ailment.86 This advice relies on a minimum of two randomized trials comparing observation to either chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).103,